Filana Therapeutics, Inc. (FLNA) Free cash flow 2016–2025
Filana Therapeutics, Inc. (FLNA) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
-$32.8MFY2025 · since FY2016: -$12.3M → -$32.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$32.8M | +71.9% |
| FY2024 | -$117.0M | -42.0% |
| FY2023 | -$82.4M | -2.8% |
| FY2022 | -$80.2M | -53.1% |
| FY2021 | -$52.4M | — |
| FY2019 | -$2.5M | — |
| FY2016 | -$12.3M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice